BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2450520)

  • 1. HTLV-I and chronic nervous diseases: present status and a look into the future.
    Koprowski H; DeFreitas E
    Ann Neurol; 1988; 23 Suppl():S166-70. PubMed ID: 2450520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HTLV-I infection of cerebrospinal fluid T cells from patients with chronic neurologic disease.
    DeFreitas E; Wroblewska Z; Maul G; Sheremata W; Ferrante P; Lavi E; Harper M; di Marzo-Veronese F; Koprowski H
    AIDS Res Hum Retroviruses; 1987; 3(1):19-32. PubMed ID: 2887183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular cloning of human T-cell lymphotrophic virus type I-like proviral genome from the peripheral lymphocyte DNA of a patient with chronic neurologic disorders.
    Reddy EP; Mettus RV; DeFreitas E; Wroblewska Z; Cisco M; Koprowski H
    Proc Natl Acad Sci U S A; 1988 May; 85(10):3599-603. PubMed ID: 2897123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of HTLV-I in tropical spastic paraparesis in Jamaica.
    Rodgers-Johnson P; Morgan OS; Mora C; Sarin P; Ceroni M; Piccardo P; Garruto RM; Gibbs CJ; Gajdusek DC
    Ann Neurol; 1988; 23 Suppl():S121-6. PubMed ID: 2894801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered subsets of peripheral blood lymphocytes in patients with HTLV-I associated myelopathy (HAM).
    Itoyama Y; Minato S; Kira J; Goto I; Sato H; Okochi K; Yamamoto N
    Neurology; 1988 May; 38(5):816-8. PubMed ID: 2896315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrathecal synthesis of IgG antibodies to HTLV-I supports an etiological role for HTLV-I in tropical spastic paraparesis.
    Ceroni M; Piccardo P; Rodgers-Johnson P; Mora C; Asher DM; Gajdusek DC; Gibbs CJ
    Ann Neurol; 1988; 23 Suppl():S188-91. PubMed ID: 2894812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of antibody to HTLV I and III in sera of Canadian patients with multiple sclerosis and chronic myelopathy.
    Rice GP; Armstrong HA; Bulman DE; Paty DW; Ebers GC
    Ann Neurol; 1986 Oct; 20(4):533-4. PubMed ID: 2878638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HTLV-I, adult T-cell leukemia, and tropical spastic paraparesis.
    Sarin PS
    Ann Neurol; 1988; 23 Suppl():S181-4. PubMed ID: 2894811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial cases of HTLV-I-associated myelopathy.
    Miyai I; Saida T; Fujita M; Kitahara Y; Hirono N
    Ann Neurol; 1987 Nov; 22(5):601-5. PubMed ID: 2892464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrovirus-associated myelopathies.
    Román GC
    Arch Neurol; 1987 Jun; 44(6):659-63. PubMed ID: 2883964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroprevalence of antibodies to HTLV-I in patients with chronic neurological disorders other than tropical spastic paraparesis.
    Mora CA; Garruto RM; Brown P; Guiroy D; Morgan OS; Rodgers-Johnson P; Ceroni M; Yanagihara R; Goldfarb LG; Gibbs CJ
    Ann Neurol; 1988; 23 Suppl():S192-5. PubMed ID: 2894813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spastic paraparesis and HTLV-I infection in Peru.
    Johnson RT; Griffin DE; Arregui A; Mora C; Gibbs CJ; Cuba JM; Trelles L; Vaisberg A
    Ann Neurol; 1988; 23 Suppl():S151-5. PubMed ID: 2894807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological findings in neurological diseases associated with antibodies to HTLV-I: activated lymphocytes in tropical spastic paraparesis.
    Jacobson S; Zaninovic V; Mora C; Rodgers-Johnson P; Sheremata WA; Gibbs CJ; Gajdusek C; McFarlin DE
    Ann Neurol; 1988; 23 Suppl():S196-200. PubMed ID: 2894814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HTLV-I-associated leukemia: a model for chronic retroviral diseases.
    Murphy EL; Blattner WA
    Ann Neurol; 1988; 23 Suppl():S174-80. PubMed ID: 2894810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA haplotype-linked high immune responsiveness against HTLV-I in HTLV-I-associated myelopathy: comparison with adult T-cell leukemia/lymphoma.
    Usuku K; Sonoda S; Osame M; Yashiki S; Takahashi K; Matsumoto M; Sawada T; Tsuji K; Tara M; Igata A
    Ann Neurol; 1988; 23 Suppl():S143-50. PubMed ID: 2894806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemialike cells.
    Osame M; Matsumoto M; Usuku K; Izumo S; Ijichi N; Amitani H; Tara M; Igata A
    Ann Neurol; 1987 Feb; 21(2):117-22. PubMed ID: 2881513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of HTLV in HIV-1 neurologic disease.
    Berger JR; Raffanti S; Svenningsson A; McCarthy M; Snodgrass S; Resnick L
    Neurology; 1991 Feb; 41(2 ( Pt 1)):197-202. PubMed ID: 1671529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
    Gessain A; Mahieux R
    Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human T-cell leukemia virus type I (HTLV-I) and blood transfusion.
    Larson CJ; Taswell HF
    Mayo Clin Proc; 1988 Sep; 63(9):869-75. PubMed ID: 2900915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of HTLV-II from a patient with chronic, progressive neurological disease clinically indistinguishable from HTLV-I-associated myelopathy/tropical spastic paraparesis.
    Jacobson S; Lehky T; Nishimura M; Robinson S; McFarlin DE; Dhib-Jalbut S
    Ann Neurol; 1993 Apr; 33(4):392-6. PubMed ID: 8489210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.